Related Experiment Video
Updated: Mar 9, 2026
05:18
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
Published on: November 22, 2024
1.6K
Noninvasive Submental Fat Compartment Treatment
1private practice, Ava MD, Beverly Hills and Santa Monica, Calif.
Plastic and Reconstructive Surgery. Global Open
|December 27, 2016
Abstract
Background:
KYBELLA, ATX-101, is an injectable form of sodium deoxycholic acid. It is currently the only Food and Drug Administration-approved injectable drug for the reduction of submental fat.
Objectives:
A literature review and discussion of the treatment of submental fat.
Results:
KYBELLA is a well-tolerated alternative for the treatment of submental fat.
Conclusions:
KYBELLA is a safe and efficacious, first in class, injectable drug for the reduction of submental fat.
